Overview
Diffuse leptomeningeal glioneuronal neoplasm (LGN) is a rare, infiltrative lesion characterized by the proliferation of glioneuronal elements within the leptomeninges, often associated with underlying genetic conditions such as trisomy 13. 1Diagnosis
Appearance typically observed postnatally, developing from mid-fetal period onwards.
Incidence increases significantly between 28-31 weeks postmenstrual age.
Presence of glial fibrillary acidic protein (GFAP)-positive glial processes in subpial layers, extending along perforating vessels into leptomeninges.
Histopathological examination crucial for definitive diagnosis. 1Management
No specific first-line treatments mentioned in the provided abstracts.
Management likely focused on supportive care and addressing underlying genetic conditions.
Further research needed for targeted therapeutic approaches. 1Special Populations
Pediatrics: LGN development noted in fetuses and neonates, particularly in those with trisomy 13, suggesting increased vigilance in high-risk populations. 1Key Recommendations
Monitor and diagnose LGN development particularly in fetuses and neonates with trisomy 13, given its association and early appearance post-20 weeks postmenstrual age. (Evidence: Moderate) 1
Histopathological examination is essential for confirming the diagnosis of LGN, focusing on GFAP expression patterns. (Evidence: Moderate) 1
Supportive care should be prioritized in management, with tailored interventions based on associated genetic conditions. (Evidence: Expert opinion) 1References
1 Iida K, Hirano S, Takashima S, Miyahara S. Developmental study of leptomeningeal glioneuronal heterotopia. Pediatric neurology 1994. link90125-2)